Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy
A major problem in translating stem cell therapeutics is the difficulty of producing stable, long-term severe left ventricular (LV) dysfunction in a large animal model. For that purpose, extensive infarction was created in sinclair miniswine by injecting microspheres (1.5 × 106 microspheres, 45 μm d...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/6940195 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564770444673024 |
|---|---|
| author | Gen Suzuki Rebeccah F. Young Merced M. Leiker Takayuki Suzuki |
| author_facet | Gen Suzuki Rebeccah F. Young Merced M. Leiker Takayuki Suzuki |
| author_sort | Gen Suzuki |
| collection | DOAJ |
| description | A major problem in translating stem cell therapeutics is the difficulty of producing stable, long-term severe left ventricular (LV) dysfunction in a large animal model. For that purpose, extensive infarction was created in sinclair miniswine by injecting microspheres (1.5 × 106 microspheres, 45 μm diameter) in LAD. At 2 months after embolization, animals (n=11) were randomized to receive allogeneic cardiosphere-derived cells derived from atrium (CDCs: 20 × 106, n=5) or saline (untreated, n=6). Four weeks after therapy myocardial function, myocyte proliferation (Ki67), mitosis (phosphor-Histone H3; pHH3), apoptosis, infarct size (TTC), myocyte nuclear density, and cell size were evaluated. CDCs injected into infarcted and remodeled remote myocardium (global infusion) increased regional function and global function contrasting no change in untreated animals. CDCs reduced infarct volume and stimulated Ki67 and pHH3 positive myocytes in infarct and remote regions. As a result, myocyte number (nuclear density) increased and myocyte cell diameter decreased in both infarct and remote regions. Coronary microembolization produces stable long-term ischemic cardiomyopathy. Global infusion of CDCs stimulates myocyte regeneration and improves left ventricular ejection fraction. Thus, global infusion of CDCs could become a new therapy to reverse LV dysfunction in patients with asymptomatic heart failure. |
| format | Article |
| id | doaj-art-9cf178ae2bff44daa17baeaf5e7a3484 |
| institution | Kabale University |
| issn | 1687-966X 1687-9678 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-9cf178ae2bff44daa17baeaf5e7a34842025-02-03T01:10:12ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/69401956940195Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based TherapyGen Suzuki0Rebeccah F. Young1Merced M. Leiker2Takayuki Suzuki3Division of Cardiovascular Medicine, University at Buffalo Clinical and Translational Research Center, Suite 7030, 875 Ellicott Street, Buffalo, NY 14203, USADivision of Cardiovascular Medicine, University at Buffalo Clinical and Translational Research Center, Suite 7030, 875 Ellicott Street, Buffalo, NY 14203, USADivision of Cardiovascular Medicine, University at Buffalo Clinical and Translational Research Center, Suite 7030, 875 Ellicott Street, Buffalo, NY 14203, USADivision of Cardiovascular Medicine, University at Buffalo Clinical and Translational Research Center, Suite 7030, 875 Ellicott Street, Buffalo, NY 14203, USAA major problem in translating stem cell therapeutics is the difficulty of producing stable, long-term severe left ventricular (LV) dysfunction in a large animal model. For that purpose, extensive infarction was created in sinclair miniswine by injecting microspheres (1.5 × 106 microspheres, 45 μm diameter) in LAD. At 2 months after embolization, animals (n=11) were randomized to receive allogeneic cardiosphere-derived cells derived from atrium (CDCs: 20 × 106, n=5) or saline (untreated, n=6). Four weeks after therapy myocardial function, myocyte proliferation (Ki67), mitosis (phosphor-Histone H3; pHH3), apoptosis, infarct size (TTC), myocyte nuclear density, and cell size were evaluated. CDCs injected into infarcted and remodeled remote myocardium (global infusion) increased regional function and global function contrasting no change in untreated animals. CDCs reduced infarct volume and stimulated Ki67 and pHH3 positive myocytes in infarct and remote regions. As a result, myocyte number (nuclear density) increased and myocyte cell diameter decreased in both infarct and remote regions. Coronary microembolization produces stable long-term ischemic cardiomyopathy. Global infusion of CDCs stimulates myocyte regeneration and improves left ventricular ejection fraction. Thus, global infusion of CDCs could become a new therapy to reverse LV dysfunction in patients with asymptomatic heart failure.http://dx.doi.org/10.1155/2016/6940195 |
| spellingShingle | Gen Suzuki Rebeccah F. Young Merced M. Leiker Takayuki Suzuki Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy Stem Cells International |
| title | Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy |
| title_full | Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy |
| title_fullStr | Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy |
| title_full_unstemmed | Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy |
| title_short | Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy |
| title_sort | heart derived stem cells in miniature swine with coronary microembolization novel ischemic cardiomyopathy model to assess the efficacy of cell based therapy |
| url | http://dx.doi.org/10.1155/2016/6940195 |
| work_keys_str_mv | AT gensuzuki heartderivedstemcellsinminiatureswinewithcoronarymicroembolizationnovelischemiccardiomyopathymodeltoassesstheefficacyofcellbasedtherapy AT rebeccahfyoung heartderivedstemcellsinminiatureswinewithcoronarymicroembolizationnovelischemiccardiomyopathymodeltoassesstheefficacyofcellbasedtherapy AT mercedmleiker heartderivedstemcellsinminiatureswinewithcoronarymicroembolizationnovelischemiccardiomyopathymodeltoassesstheefficacyofcellbasedtherapy AT takayukisuzuki heartderivedstemcellsinminiatureswinewithcoronarymicroembolizationnovelischemiccardiomyopathymodeltoassesstheefficacyofcellbasedtherapy |